Journal
Cancer Discovery
Publication Date
11-1-2024
Volume
14
Issue
11
First Page
2224
Last Page
2242
Document Type
Open Access Publication
DOI
10.1158/2159-8290.CD-24-0519
Rights and Permissions
Mazzone PJ, Bach PB, Carey J, Schonewolf CA, Bognar K, Ahluwalia MS, Cruz-Correa M, Gierada D, Kotagiri S, Lloyd K, Maldonado F, Ortendahl JD, Sequist LV, Silvestri GA, Tanner N, Thompson JC, Vachani A, Wong KK, Zaidi AH, Catallini J, Gershman A, Lumbard K, Millberg LK, Nawrocki J, Portwood C, Rangnekar A, Sheridan CC, Trivedi N, Wu T, Zong Y, Cotton L, Ryan A, Cisar C, Leal A, Dracopoli N, Scharpf RB, Velculescu VE, Pike LRG. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection. Cancer Discov. 2024 Nov 1;14(11):2224-2242. doi: 10.1158/2159-8290.CD-24-0519 This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. ©2024 The Authors; Published by the American Association for Cancer Research
Recommended Citation
Mazzone, Peter J; Gierada, David; and et al., "Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection." Cancer Discovery. 14, 11. 2224 - 2242. (2024).
https://digitalcommons.wustl.edu/oa_4/4449
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
